Kontigo Care AB | Income Statement

Fiscal year is January-December. All values SEK Thousands.
2014
2015
2016
2017
Sales/Revenue
-
2.60
1,082.20
6,231.30
Cost of Goods Sold (COGS) incl. D&A
-
17,909.80
21,178.70
20,102.80
Gross Income
-
17,907.20
20,096.50
13,871.40
SG&A Expense
2,780.90
-
198.00
-
EBIT
2,780.90
17,907.20
19,220.00
13,871.40
Unusual Expense
-
-
-
75.30
Non Operating Income/Expense
1,590.00
3,668.00
-
75.10
Interest Expense
15.50
47.10
410.40
345.30
Pretax Income
1,206.10
14,285.30
19,630.00
14,365.90
Consolidated Net Income
1,206.10
14,285.30
19,630.00
14,365.90
Net Income
1,206.10
14,285.30
19,630.00
14,365.90
Net Income After Extraordinaries
1,206.10
14,285.30
19,630.00
14,365.90
Net Income Available to Common
1,206.10
14,285.30
19,630.00
14,365.90
EPS (Basic)
-
2.74
2.05
0.79
Basic Shares Outstanding
-
5,200.60
9,575.60
18,144.90
EPS (Diluted)
-
2.75
2.05
0.79
Diluted Shares Outstanding
-
5,200.60
9,575.60
18,144.90
EBITDA
2,780.90
17,907.20
17,278.10
11,466.60
Other Operating Expense
-
-
1,074.50
-
Non-Operating Interest Income
0.40
1.00
0.40
1.20

About Kontigo Care AB

View Profile
Address
Påvel Snickares Gränd 12
Uppsala UP 753 30
Sweden
Employees -
Website http://www.kontigocare.com
Updated 09/14/2018
Kontigo Care AB engages in the development of mobile health solutions for addiction treatment. It develops TripleA that consists of breathalyzer, mobile application, and database. The company was founded by Daniel Benitez on December 12, 2013 and is headquartered in Uppsala, Sweden.